Exelixis | Laba Kotor Pada Penjualan



Gross Profit On Sales Perubahan Tanggal
Acadia Pharmaceuticals USD 223.92M 13.87M 2025-03
Agios Pharmaceuticals USD 7.64M 1.83M 2025-03
Amgen USD 5.54B 430M 2025-03
AstraZeneca USD 11.35B 819M 2025-03
Bayer EUR 8.11B 2.11B 2025-03
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Cytokinetics -160545000 81.19M 2024-09
Eisai JPY 147.63B 22.57B 2025-03
Eli Lilly USD 10.5B 624.7M 2025-03
Exelixis USD 548.79M 12.52M 2025-06
Genmab DKK 673M 5.43B 2025-03
Glaxosmithkline GBP 5.6B 94M 2024-12
Incyte USD 1.14B 151.67M 2025-06
Ionis Pharmaceuticals USD 448M 317.85M 2025-06
MacroGenics USD 13.86M 94.98M 2024-12
Merck USD 12.99B 224M 2025-06
Moderna USD 17M 403M 2025-03
Neurocrine Biosciences USD 563.4M 55M 2025-03
Novartis USD 11.51B 1.12B 2025-06
Pfizer USD 11.12B 987M 2025-03
Sanofi EUR 5.36B 4.71B 2024-12
Takeda JPY 671.32B 55.93B 2025-03
Ultragenyx Pharmaceutical USD 110.63M 37.35M 2025-03
Xencor 32.73M 77.88M 2025-03


Exelixis Laba Kotor Pada Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Aug 2025.